• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司洗脱支架置入术后的造影晚期迟滞现象。

"Angiographic late catch-up" phenomenon after sirolimus-eluting stent implantation.

机构信息

Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital, Cardiovascular Research Institute, Busan, South Korea.

出版信息

Int J Cardiol. 2012 Sep 20;160(1):48-52. doi: 10.1016/j.ijcard.2011.03.024. Epub 2011 Aug 6.

DOI:10.1016/j.ijcard.2011.03.024
PMID:21824671
Abstract

BACKGROUND

Although several randomized trials have shown that sirolimus-eluting stent (SES) substantially reduces in-stent restenosis, recent studies have suggested the possibility of late catch-up after SES implantation. We investigated long-term angiographic outcomes after SES implantation in real-world practice.

METHODS

This study was conducted on 195 patients with 253 lesions who underwent the first and long-term angiographic follow-up after SES implantation. First follow-up was done at near 6 months after SES implantation. Long-term angiographic follow-up was defined as that performed at least 36 months after index procedure. Angiographies in patients who experienced target lesion revascularization at the time of the first angiographic follow-up were excluded from the current analysis.

RESULTS

Minimal luminal diameter at long-term angiographic follow-up was significantly smaller compared with that at the first follow-up (2.21 ± 0.65 vs. 2.40 ± 0.55, p<0.001). In-stent late lumen loss between the first and long-term follow-up tended to be larger compared with that between SES implantation and the first follow-up (0.19 ± 0.47 vs. 0.15 ± 0.39, p=0.298). There was a trend for increased incidence of coronary artery aneurysm (1.6% and 7.5% at the first and long-term follow-up) and stent fracture (4.3% and 10.3%). Two stent aneurysms and one stent fracture were related with definite very late stent thrombosis.

CONCLUSION

An "angiographic late catch-up" phenomenon and a trend toward increased incidence of coronary artery aneurysm and stent fracture were found at a median 46.5-month angiographic follow-up compared with a median 6-month follow-up.

摘要

背景

虽然几项随机试验表明,西罗莫司洗脱支架(SES)可显著减少支架内再狭窄,但最近的研究表明 SES 植入后可能会出现晚期追赶现象。我们研究了 SES 植入后真实世界实践中的长期血管造影结果。

方法

本研究纳入了 195 例 253 处病变患者,这些患者在 SES 植入后进行了首次和长期血管造影随访。首次随访在 SES 植入后近 6 个月进行。长期血管造影随访定义为指数手术后至少 36 个月进行的随访。在首次血管造影随访时发生靶病变血运重建的患者,其血管造影结果被排除在本分析之外。

结果

与首次随访时相比,长期血管造影随访时的最小管腔直径明显较小(2.21±0.65 vs. 2.40±0.55,p<0.001)。SES 植入后与首次随访相比,支架内晚期管腔丢失在首次和长期随访之间趋于更大(0.19±0.47 vs. 0.15±0.39,p=0.298)。冠状动脉瘤的发生率呈增加趋势(首次和长期随访分别为 1.6%和 7.5%)和支架断裂(首次和长期随访分别为 4.3%和 10.3%)。两个支架瘤和一个支架断裂与明确的极晚期支架血栓形成有关。

结论

与中位 6 个月随访相比,在中位 46.5 个月血管造影随访时发现了“血管造影晚期追赶”现象以及冠状动脉瘤和支架断裂发生率增加的趋势。

相似文献

1
"Angiographic late catch-up" phenomenon after sirolimus-eluting stent implantation.西罗莫司洗脱支架置入术后的造影晚期迟滞现象。
Int J Cardiol. 2012 Sep 20;160(1):48-52. doi: 10.1016/j.ijcard.2011.03.024. Epub 2011 Aug 6.
2
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.紫杉醇洗脱支架与西罗莫司洗脱支架治疗西罗莫司洗脱支架内再狭窄的随机试验:ISAR-DESIRE 2(冠状动脉支架置入术和血管造影结果:药物洗脱支架治疗支架内再狭窄 2)研究。
J Am Coll Cardiol. 2010 Jun 15;55(24):2710-6. doi: 10.1016/j.jacc.2010.02.009. Epub 2010 Mar 11.
3
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II).在原发性完全闭塞性冠状动脉病变的治疗中,无主要不良心脏事件的患者在五年血管造影时晚期管腔直径的迟发获得:对比金属裸支架与雷帕霉素洗脱支架治疗完全闭塞性病变的随机比较(PRISON II)。
EuroIntervention. 2013 Jun 22;9(2):212-9. doi: 10.4244/EIJV9I2A36.
4
Late restenosis following sirolimus-eluting stent implantation.西罗莫司洗脱支架置入术后晚期再狭窄。
JACC Cardiovasc Interv. 2011 Jan;4(1):123-8. doi: 10.1016/j.jcin.2010.09.013.
5
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).晚期临床结果与佐他莫司和西罗莫司洗脱支架。ENDEAVOR III 试验(美敦力 Endeavor 药物 [ABT-578]洗脱冠状动脉支架系统与 Cypher 西罗莫司洗脱冠状动脉支架系统在初发原生冠状动脉病变中的随机对照试验)的 5 年随访结果。
JACC Cardiovasc Interv. 2011 May;4(5):543-50. doi: 10.1016/j.jcin.2010.12.014.
6
Angiographic late lumen loss at the site of overlap of multiple Cypher™ sirolimus-eluting stents: ALSOCE study.多枚 Cypher™西罗莫司洗脱支架重叠部位的血管造影晚期管腔丢失:ALSOCE 研究。
J Cardiol. 2011 Mar;57(2):187-93. doi: 10.1016/j.jjcc.2010.11.005. Epub 2010 Dec 21.
7
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial.比较依维莫司洗脱支架和西罗莫司洗脱支架治疗长段冠状动脉病变患者的疗效:一项随机 LONG-DES-III(经皮治疗长段 native 冠状动脉病变的药物洗脱支架-III 试验)研究。
JACC Cardiovasc Interv. 2011 Oct;4(10):1096-103. doi: 10.1016/j.jcin.2011.05.024.
8
Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents.药物洗脱支架中是否存在“晚期追赶”现象:西罗莫司与紫杉醇洗脱支架的系列定量冠状动脉造影分析的见解。
Am Heart J. 2010 Mar;159(3):446-453.e3. doi: 10.1016/j.ahj.2010.01.001.
9
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.糖尿病患者中雷帕霉素洗脱支架和依维莫司洗脱支架植入术后晚期管腔丢失和内膜增生:糖尿病和药物洗脱支架(DiabeDES III)血管造影和血管内超声试验。
EuroIntervention. 2011 Jul;7(3):323-31. doi: 10.4244/EIJV7I3A56.
10
Late target lesion revascularization after implantation of sirolimus-eluting stent.
Catheter Cardiovasc Interv. 2008 Feb 15;71(3):299-303. doi: 10.1002/ccd.21327.

引用本文的文献

1
Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis.西罗莫司洗脱生物可吸收支架(XINSORB)与金属支架治疗冠状动脉狭窄的三年临床结果
Ann Transl Med. 2020 Nov;8(22):1489. doi: 10.21037/atm-20-6739.
2
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.既往冠状动脉旁路移植术后患者应用新一代药物洗脱支架的长期预后。
J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212.
3
Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study.
依维莫司洗脱支架用于小冠状动脉病变和非小冠状动脉病变的初始及晚期疗效:来自评估延迟晚期丢失研究
Heart Vessels. 2017 Dec;32(12):1415-1423. doi: 10.1007/s00380-017-1018-z. Epub 2017 Jul 7.